Neuroendocrine Neoplasms
Original Article Pancreatic neuroendocrine neoplasms: computed tomography features and the correlation to pathological tumor grade
... pancreatic neuroendocrine neoplasms (pNENs) and to identify useful CT findings for differentiating tumors with different pathological ...G1 neuroendocrine tumors (NETs), 5 patients had G2 NETs, and ...
10
Pancreatic neuroendocrine neoplasms a series of six cases
... Pancreatic Neuroendocrine Neoplasms (PanNENs) are relatively uncommon tumors that account for 1% to 2% of all pancreatic ...A neuroendocrine tumour arises in any organ derived from primitive ...
5
Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future
... Pancreatic neuroendocrine neoplasms (pNENs) are rare tumors accounting for only 1-2% of all pancreatic ...and neuroendocrine carcinoma: NEC) on the basis of Ki-67 proliferation index and mitotic ...
14
Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience
... Gastric neuroendocrine neoplasms (G-NENs) are a heterogeneous group of neoplasms, showing different clinicopathological characteristics and behaviors, and it composed of cells containing ...
11
Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China
... underwent surgery. This phenomenon may be partly due to higher rates of preoperative symptoms, such as massive gastrointestinal bleeding and obstruction, which required emergent surgery. Also, compared with pancreatic ...
9
Original Article Transcatheter arterial chemoembolization for patients with hepatic metastasis of nonfunctional pancreatic neuroendocrine neoplasms
... atic neuroendocrine neoplasms with LM, aged from 26 to 79 years (mean, 54 ± 11 years), con- sisting 20 males and 15 ...teropancreatic neuroendocrine tumor classifi- cation criteria [19-21], the ...
11
Imaging presentation of pancreatic neuroendocrine neoplasms
... Pancreatic neuroendocrine neoplasms (P-NENs) are the second most common solid pancreatic ...these neoplasms, especially in those cases in which surgery is the treatment of ...
11
Updates on the Role of Molecular Alterations and NOTCH Signaling in the Development of Neuroendocrine Neoplasms
... Abstract: Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of rare malignancies mainly originated from hormones secreting cells, which are widespread in human ...on neuroendocrine cells ...
17
Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study
... the neuroendocrine neoplasms of je- ...of neuroendocrine neoplasms of jejunum/ileum is high, which is only ...gastrointestinal neuroendocrine neo- plasms were mainly ...
9
Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms
... Neuroendocrine neoplasms (NENs) have also been associated with EPNS [7]. These neoplasms comprise a heterogeneous group of mostly well-differentiated tumours with a generally favourable ...
9
<p>CD56 Expression Is Associated with Biological Behavior of Pancreatic Neuroendocrine Neoplasms</p>
... study. Neuroendocrine markers, such as CgA, Syn and CD56 have been widely used in PNET pathological ...between neuroendocrine markers and PNET grades has not been totally ...
7
Neuroendocrine neoplasms of the larynx: An overview
... of neuroendocrine neoplasm requires the presence of both neuroendocrine morpholo- gies by light microscopy and demonstration of neuroendocrine differentiation by immunohisto- chemistry or electron ...
13
Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study
... Results: Mean age was 51.83 ± 14.03 and the male-to-female ratio was 1.5:1. Primary sites were the rectum (58.93%), pancreas (13.69%), stomach (9.52%), duodenum (5.36%), colon (4.76%), appendix (4.76%), ileum (2.38%) and ...
9
PI3K-AKT-mTOR-Signaling and beyond: the Complex Network in Gastroenteropancreatic Neuroendocrine Neoplasms
... The regulatory impact of PI3K could be vali- dated by preclinical studies with PI3K inhibitors. LY294002, a quercetin analogue and PI3K inhibitor, decreased cell proliferation in non-gastrointestinal ...
30
Original Article Neuroendocrine neoplasms of the middle ear: report of 2 cases and review of the literature
... ear neuroendocrine adenomas need to be differentially diagnosed with a range of dis- eases, including cervical tympanic gangliono- ma, adenoid cystic carcinoma, endolymphatic papillary tumor, meningioma with ...
6
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms
... patients treated at the ENETS (European NeuroEndocrine Tumor Society) center of Naples.. Patients and treatment.[r] ...
9
Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors
... The aim of this study is to identify the magnetic resonance imaging (MRI) features in differentiating pancreatic neuroendocrine tumors (PanNETs) grade 1/2 (G1/G2) and pancreatic neuroe[r] ...
10
Original Article Clinical characteristics and treatment options of patients with G3 gastroenteropancreatic neuroendocrine neoplasms in China
... Gastroenteropancreatic neuroendocrine neo- plasms (GEP-NENs) are rare types of tumors which express special diagnostic biomarkers. The heterogeneity of GEP-NENs determines dif- ferent outcomes. According to 2010 ...
7
Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study
... Although previous papers [ 1 , 2 , 11 ] have advocated re-assessment of the Ki-67 index throughout the disease course, or the progression from primary to metastatic sites, reports on whe[r] ...
7
Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms
... Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.. Cancer and the chemokine network.[r] ...
13